BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 22, 2006
View Archived Issues
Speedel retains rights to SPP-200
Read More
MorphoSys signs second PER.C6 license agreement
Read More
TolerRx raises funding to develop TRX-4
Read More
Alantos begins phase I study with ALS 2-0426
Read More
Polyfunctional CD8+ HIV-1-specific T-cell responses seen with Remune
Read More
TNX-355 activity described in vitro and in clinical trial
Read More
GS-9137/ritonavir can be administered with zidovudine and emtricitabine/tenofovir
Read More
BTA-798 begins phase Ib study
Read More
Novel agents for treating neurological disorders disclosed in recent patent literature
Read More
Preclinical findings support the application of talnetant for schizophrenia
Read More
Novel treatment options for metabolic disorders described in recent Merck and Dainippon patents
Read More
Novel antiinfective agents disclosed in recent patent literature
Read More
TAMs get attention as drug targets
Read More
Epix and Predix complete merger
Read More
Geron report on the anti-HIV activity of their telomerase activator TAT-0002
Read More
Sirion Therapeutics completes merger with Sytera
Read More
Antisoma updates AS-1404 development progress
Read More
Novel agents for thrombotic disorders disclosed in recent Astellas patent
Read More
Further findings for Viprovex in anthrax testing
Read More
Cesamet now available for CINV
Read More
MaxCyte and Medinet collaborate on immuno-cell therapy
Read More
Marqibo studied in phase II trial for relapsed and refractory ALL
Read More
Enrollment completed in European phase III trial for LidoPAIN SP
Read More
Tindamax submitted for bacterial vaginosis
Read More
NeuroSearch cleared to begin phase IIb obesity study of tesofensine
Read More
Approvable letter for Arxxant
Read More
MedImmune files IND for MT-103
Read More